Operations shouldn't gate science.

Clinical operations infrastructure for emerging biotechs. Built by operators, designed for lean teams running real trials.

Why we built this

Why we built this.

Every clinical ops person knows the problems. We bonded over them in hiring interviews and vented about them after working group meetings. We rolled our eyes at the next vendor coming in with a tool that wasn't built for us. And then we went back to rebuilding the same operational foundation from scratch. Every company, every trial.

Nothing was designed for lean biotech. What worked, we couldn't afford. So we built it ourselves.

Bowlyn is the thing we couldn't find and couldn't hire. We meet clients where they are. Because great science shouldn't get grounded by ops.

Keel

Study startup infrastructure.

Every new trial requires building an operational foundation: SOPs, governance framework, risk register, regulatory pathways country by country. Bring a synopsis or a finalized protocol; we deliver the foundation. Available today.

  • Tailored to your trial, countries, and CRO
  • Delivered in days, not months
Schedule a discovery call
SOPs

Operating procedures written for your trial, your team, your stage.

Governance

Decision frameworks, escalation paths, oversight that actually fits a lean team.

Risk register

Tracked from day one, structured for review with your CRO and board.

Regulatory pathways

Country-by-country mapping aligned to your indication and timeline.

Bridge

AI-drafted, operator-reviewed clinical operations guidance.

Bridge answers any clinical operations question your team has: AI-drafted against your protocol, operator-reviewed before sending, delivered in hours. Launching Q3 2026.

  • Grounded in your specific protocol
  • Operator-reviewed, every answer
Get early access

Built on BAA-covered AWS infrastructure with end-to-end encryption.

01

You ask.

Submit a question through the portal or by email. No ticketing, no queue.

02

Bridge drafts.

An AI agent drafts a first-pass response grounded in your specific protocol.

03

An operator reviews.

An experienced clinical operator edits, approves, and sends the answer back. Usually in hours.

Compass

Sponsor-controlled CRO oversight.

Emerging biotech sponsors hold ultimate regulatory accountability under ICH E6(R3), but most lean clinical ops teams lack the infrastructure to demonstrate active oversight under inspection. Compass closes that gap.

Delivered as a structured oversight engagement today, sponsor-controlled by default, independent by design. We're now selecting design partners.

Schedule a discovery call
FAQ

Common questions.

How is Bridge different from ChatGPT or other LLMs?
ChatGPT gives you a generic answer from the internet. Bridge gives you an operator-grade answer grounded in your specific protocol, reviewed by an experienced clinical operator before it reaches you. The difference shows up when you have to act on the answer.
Is my data safe?
Yes. Bridge runs on BAA-covered AWS with end-to-end encryption. Your protocol and conversations are isolated, encrypted at rest and in transit, and never used for AI model training.
What does engagement look like across the three products?
Each one is structured differently. Keel is a one-time engagement: bring your protocol, we deliver the foundation. Compass is structured around your trial's oversight cadence, scoped month-to-month. Bridge will be month-to-month when it launches in Q3 2026. No annual commitments anywhere.
What therapeutic areas do you cover?
All of them. Our operational frameworks are indication-agnostic: study startup, CRO oversight, regulatory pathways, risk management. We adapt to the complexity of your specific program.

Have a question we didn't answer? Schedule a call →